A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
NCT00556998
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetics
Interventions
DRUG:
Voriconazole
Sponsor
Pfizer